在混合心脏和败血性休克中最佳ECLS支持:ELSO注册分析
Lyana Labrada1, Mohammad Alarfaj2, Lena Tran3
1Department of Cardiovascular Diseases, Temple University Hospital, Philadelphia, Pennsylvania, USA.
JACC. Advances
|July 24, 2025
概括
在混合休克患者中,通过静脉动脉外体生命支持 (VA-ECLS) 提供更高的循环支持,显示出增加存活到出院的趋势. 需要进一步的研究来证实这些发现,在这个高死亡率的患者群体.
科学领域:
- 心血管医学 心血管医学
- 临界护理医学 临界护理医学
- 冲击病理生理学 冲击病理生理学
背景情况:
- 与单独的心脏性休克相比,混合心脏性和败血性休克的死亡风险更高.
- 这种复杂的冲击状态表现出明显的血液动力学特征,需要专门的管理.
研究的目的:
- 调查静脉动脉外体生命支持 (VA-ECLS) 提供的循环支持水平与混合休克患者的生存结果之间的关联.
- 为了确定更高的VA-ECLS流量是否与更好的释放存活率相关.
主要方法:
- 利用体外生命支持组织 (ELSO) 注册表来识别被诊断患有混合 (心脏和败血症) 休克的成年患者.
- 在2017年至2022年期间需要VA-ECLS的患者根据开始后24小时的循环支持水平进行分类:较低 (<2.2 L/min/m2) 与较高 (≥2.2 L/min/m2).
主要成果:
- 总共有452名VA-ECLS混合休克患者被分析,总死亡率为63%.
- 与死亡率增加相关的因素包括年龄较大,VA-ECLS前心脏骤停和较高的查尔森并发症指数.
- 接受更高VA-ECLS支持的患者表现出数值趋势,改善了离院生存率 (42.6%与33.8%,P=0.063).
结论:
- 需要VA-ECLS的混合休克患者面临着相当大的死亡风险.
- 在启动后24小时内,更高水平的VA-ECLS支持可能与更好的生存趋势有关,这需要进一步调查.
- 这些发现产生了假设,并强调需要进行额外的研究,以优化混合冲击中的VA-ECLS策略.
相关概念视频
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
78
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
78
01:30Heart Failure IV: Classification and Diagnostic Evaluation
33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
01:23Cardiopulmonary Resuscitation III: AED Use
70
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
70
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:26Acute Coronary Syndrome V: Nursing Management
39
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
39